SPHK1 and cancer: A study in the model organism Dictyostelium discoideum (a eukaryote species that belongs to the phylum Amoebozoa) showed that SPHK activity regulated the sensitivity to cisplatin, but not doxorubicin, etoposide and 5-fluoruracil, indicating the anti-cancer drug specificity.